Effect of US Drug Enforcement Administration's Rescheduling of Hydrocodone Combination Analgesic Products on Opioid Analgesic Prescribing

被引：100

作者：

Jones, Christopher M. ^{[1
]}

Lurie, Peter G.

Throckmorton, Douglas C. ^{[2
]}

机构：

[1] US Dept HHS, Off Assistant Secretary Planning & Evaluat, Washington, DC 20201 USA

[2] US FDA, Off Commissioner, Silver Spring, MD USA

来源：

关键词：

D O I：

10.1001/jamainternmed.2015.7799

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：399 / +

页数：4

共 6 条

[1]

[Anonymous], ADDR PRESCR DRUG AB

[2]

Center for Behavioral Health Statistics and Quality Substance Abuse and Mental Health Services Administration, FED REG

[3]

Drug Enforcement Administration Department of Justice, 2014, Fed Regist, V79, P49661

[4]

*IMS HLTH, NAT PRESCR AUD

[5]

Johnson H, 2014, MMWR-MORBID MORTAL W, V63, P569

Rosenblum, Andrew ;

Parrino, Mark ;

Schnoll, Sidney H. ;

Fong, Chunki ;

Maxwell, Carleen ;

Cleland, Charles M. ;

Magura, Stephen ;

Haddox, J. David .